Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr 3;2(2):otaa021.
doi: 10.1093/crocol/otaa021. eCollection 2020 Apr.

Reversing the Tide: Improving the Recruitment of Patients With Inflammatory Bowel Disease in Clinical Trials in the United States

Parakkal Deepak  1
Affiliations
Editorial

Reversing the Tide: Improving the Recruitment of Patients With Inflammatory Bowel Disease in Clinical Trials in the United States

Parakkal Deepak. Crohns Colitis 360. .

Abstract

While the number of inflammatory bowel disease (IBD) clinical trials has been increasing, there is decreasing participation in these trials with under-representation of younger patients and those with milder disease and in community settings. Innovative methods to increase recruitment and participation through the use of social media tools, apps, electronic medical record-based patient finding algorithms, and remote monitoring methods are suggested.

Keywords: Crohn’s disease; RCT; characteristics; clinical trials; eligibility; enrollment; inflammatory bowel disease; participation; randomized controlled trials; trends; ulcerative colitis.

PubMed Disclaimer

Comment on

References

    1. Ananthakrishnan AN, Kaplan GG, Ng SC. Changing global epidemiology of inflammatory bowel diseases-sustaining healthcare delivery into the 21st century. Clin Gastroenterol Hepatol. 2020. doi: 10.1016/j.cgh.2020.01.028. - DOI - PubMed
    1. Ehrlich OG, Testaverde J, Heller C, et al. Crohn’s disease and ulcerative colitis patient perspectives on clinical trials and participation. medRxiv. 2019:19000273.
    1. Johnson C, Barnes EL, Zhang X, et al. Trends and characteristics of clinical trials participation for inflammatory bowel disease in the United States: a Report from IBD partners. Crohn’s Colitis 360. 2020. - PMC - PubMed
    1. Wood D, Kosa K, Brown D, et al. Preferences of adult patients with inflammatory bowel disease for attributes of clinical trials: evidence from a choice-based conjoint analysis. Crohn’s Colitis 360. 2020;2:otz048. - PMC - PubMed
    1. Morain SR, Largent EA. Recruitment and trial-finding apps-time for rules of the road. J Natl Cancer Inst. 2019;111:882–886. - PMC - PubMed

LinkOut - more resources